Cooley represented Andreessen Horowitz (a16z), a Silicon Valley-based venture capital firm that backs bold entrepreneurs building the future through technology, on the $500 million closing of its Biotech Ecosystem Venture Fund – a newly formed, first-of-its-kind venture capital fund to fuel broader innovation in human health.
